Status:
UNKNOWN
Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.
Lead Sponsor:
TC Erciyes University
Conditions:
Prostate Cancer
Lymph Node Metastases
Eligibility:
MALE
18-75 years
Phase:
PHASE4
Brief Summary
Standard treatment of local or locally advanced prostate cancer is radical prostatectomy (RRP) surgery. During RRP in certain patients extended lymph node dissection (ELND) is recommended. to detect e...
Detailed Description
50 patients with diagnosis of local or locally advance prostate cancer and having LN invasion probability between 7-50% on 2018 Briganti Nomogram will be included to this study. Before Laparoscopic r...
Eligibility Criteria
Inclusion
- Histologically confirmed locally limited prostate cancer;
- Intermediate or high risk tumor
- Recommended and planned prostatectomy;
- Completed and signed written consent;
- Voluntarily agreement to participate in this study
- Age of the study participants ≥ 18 years.
Exclusion
- Allergic reaction to active ingredient (indocyanine green);
- Iodine allergy;
- Hyperthyroidism;
- High-grade renal impairment;
- High-grade hepatic insufficiency;
- Unwillingness to the storage and disclosure of pseudonymous disease and personal data
- psychiatric pre-existing conditions or other circumstances that make a cooperation by the patient in question
Key Trial Info
Start Date :
November 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 8 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04882618
Start Date
November 8 2019
End Date
November 8 2021
Last Update
May 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Ercieys University, Faculty Of Medicine,
Kayseri, Turkey (Türkiye), 38039